Your Article Summary
See Latest ArticlesTargeting lymphocyte activation to treat rheumatoid arthritis
Joint, Bone, Spine, 06/25/09
Falgarone G et al. - In RA patients, abatacept is effective in decreasing the arthritis, pain, disability, fatigue, and radiological joint damage. Abatacept provides lasting remissions or low levels of disease activity and therefore constitutes a valuable addition to the current therapeutic armamentarium for RA, which is hoped to make a full remission an attainable goal in the overall population of RA patients.
Related Articles
Abatacept for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 94%
New Biologic Drug Is Effective Against Rheumatoid Arthritis
ScienceDaily, 10/07/09
Relevance Score: 80%
Today in Arthritis/Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Charnley Low-Friction Arthroplasty in Young Patients with Osteoarthritis
Journal of Bone and Joint Surgery, 12/03/09
Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes
BMC Musculoskeletal Disorders, 12/03/09
S100 Calgranulins in inflammatory arthritis
Immunology & Cell Biology, 12/02/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis
Journal of Bone and Mineral Metabolism, 12/03/09
ALO-01 (Morphine Sulfate and Naltrexone Hydrochloride) Extended-Release Capsules in the Treatment of Chronic Pain of Osteoarthritis of the Hip or Knee: Pharmacokinetics, Efficacy, and Safety
The Journal of Pain, 12/02/09
The effect of cessation of raloxifene treatment on bone turnover in postmenopausal women
Bone , 12/01/09